MOSCOW, April 24. /TASS/: Rostec plans to register the vaccine against the coronavirus and influenza that is currently developing, by the end of 2021 or at the beginning of 2022, Chief Executive Officer of Russia's state corporation told Sergey Brilev’s news show on Rossiya-1 on Saturday.
"Hopefully we will be able to register [the vaccine] at early as by the end of the year or probably at the beginning of next year," he said.
The vaccine will protect simultaneously from the coronavirus and influenza, according to Chemezov. "Instead of two vaccines, two shots, we can give only one," he noted.
It was reported in March that the national immunobiological company Nacimbio (an affiliate of Rostec) was developing its own anti-coronavirus vaccine at Microgen and FORT facilities. The development was at an early stage, Rostec noted then.
To date, three vaccines have been registered in Russia: Sputnik V by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry, EpiVacCorona developed by the Vector State Research Center of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, as well as CoviVac created by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences.
